The Cat Health Company

10/05/2026

What a weekend! 🚀 We had the absolute pleasure of taking the stage at two of the most important events in the longevity space.

In Boston, our CEO Alexandru Ioan Voda presented "Reproducibility-Aware AI for Drug Discovery" at ARDD. At the same time in Toronto, our COO Alexandru Băcița spoke at the Animal Longevity Summit on "Bridging computational prediction and clinical endpoints in feline longevity therapeutics." 🧬

It was great to finally share some of the work we've been building over the past two years. It was even better to see what extreme engagement this has generated with collaborative pharmaceutical strategies, investors, and most importantly veterinarians and cat parents.

Now back and working through a very full inbox. More news soon. 👀

09/29/2026

Dr. Matt Kaeberlein has officially joined The Cat Health Company’s Scientific Advisory Board.

After co-founding the Dog Aging Project and spending decades studying the biology of aging, Dr. Kaeberlein will help guide our therapeutic pipeline and clinical research strategy. A lot more to share in the coming weeks. Stay tuned. 😺

09/22/2026

PURR-001 increased body mass and muscle thickness in a small placebo-controlled feline study as TCHC signs its first European licensing deal.

09/21/2026

We are excited to announce our new partnership with Ad Atomica! This project is designing new classes of safe and effective molecules for elderly cats. 🐈‍⬛

09/16/2026

Milestone unlocked! 🐈 We’ve officially signed our first pharma licensing deal with Vetro Solutions for PURR-001, targeting feline sarcopenia.

Teaming up with Vetro is an amazing start. Expect more updates soon as we bring together a larger group of companies to help develop, approve, and distribute our therapeutics.

Because our cats deserve more tomorrows and a better quality of life. 😺

09/16/2026

😸

The Cat Health Company Reports Positive Clinical Results in Geriatric Feline Study - Pet Age bit.ly/4xTQItf
The Cat Health Company

08/19/2026

We’ve just published what we believe is the first clinical trial of a treatment for primary age-related sarcopenia in cats. 💊😼

In a randomized, double-blind, placebo-controlled trial, our multi-target therapeutic showed significant positive effects on key measures of age-related muscle loss vs. placebo. 💪

A step toward treating one of the most consequential and under-studied manifestations of aging in cats.

Preprint linked in the comments.

08/08/2026

Happy International Cat Day to all our fluffy friends! 🐈 To celebrate the best companions on the planet, we have some awesome news coming very soon. Stay tuned 😼📈

08/06/2026

Meet the humans (and felines) behind The Cat Health Company! 👋 Vlad thinks he’s safe, but the Cat Distribution System is already working ... How long do you give him? ⌛😼

07/24/2026

This is what's in our heads at The Cat Health Company every single day. 😆 We are focused on one thing: creating the first therapeutics that directly target the root causes of aging in cats. 🐈🧬